Author | Douglas Yee, MD | OncLive

Author | Douglas Yee, MD

Articles

Dr. Yee Discusses the Categorization of Triple-Negative Breast Cancer

August 28, 2018

Video

Douglas Yee, MD, professor of medicine and pharmacology, Hematology, Oncology and Transplant, medical oncologist, University of Minnesota, discusses the categorization of patients with triple-negative breast cancer.

Dr. Yee on Neoadjuvant Therapy for Triple-Negative Breast Cancer

July 30, 2018

Video

Douglas Yee, MD, professor of medicine and pharmacology, Hematology, Oncology and Transplant, medical oncologist, University of Minnesota, discusses neoadjuvant therapy for patients with triple-negative breast cancer.

Dr. Yee on Phase II ADAPT Trial Results for HER2+/HR+ Breast Cancer

September 14, 2015

Video

Douglas Yee, MD, professor of medicine and pharmacology, Hematology, Oncology and Transplantation, Department of Medicine, medical oncologist, University of Minnesota, discusses the results of the phase II ADAPT trial, which examined T-DM1 in patients with HER2-positive, HR-positive early-stage breast cancer.

Dr. Yee on Neoadjuvant Pertuzumab in HER2-Positive Breast Cancer

July 29, 2015

Video

Douglas Yee, MD, professor of medicine and pharmacology, Hematology, Oncology and Transplantation, Department of Medicine, medical oncologist, University of Minnesota, discusses the research that led to the FDA approval of neoadjuvant pertuzumab as part of a combination regimen for patients with HER2-positive breast cancer.

x